ReviewClinical Medicine Insights. Oncology2022

Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges.

Katarzyna Uchimiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.